4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-060968
EVP, Research & CSO sold 2,930 shares at $30.00 ($87,900)
- EVP, Research & CSO acquired 2,930 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-11-27 | Option exercise | +2,930 | $1.53 | $4,483 | 26,630 | D |
| Virgin Herbert EVP, Research & CSO | 2020-11-27 | Sale | −2,930 | $30.00 | $87,900 | 23,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-11-27 | Option exercise · Stock Option (Right to Buy) | −2,930 | 442,900 | D | ||
| Open-market sales · 2,930 sh · avg $30.00 · $87,900 | |||||||
Loading xslF345X03/doc4.xml…